Drug Development

Clinical Trials Clinical Research Therapeutics Regulatory Affairs Regulatory Approval Weight-loss Drugs Oncology AI in Healthcare Biosimilars Pharmaceutical Research Biotechnology FDA Approval Biologics Therapeutic Approaches Therapeutic Research Stelara Loss of Exclusivity Mifepristone Ruling Alzheimer's Disease Intellectual Property Scientific Research Tyrosine Kinase Inhibitors Pharmaceuticals Combination Therapy GLP-1 Drugs Innovative Therapies Therapeutic Segments Preclinical Research Efficacy Studies Subcutaneous Administration Experimental Treatments Safety and Efficacy Research Studies Bioequivalence Characterization Techniques Alzheimer's Phase 2 Trials Breakthrough Therapy Designation Phase 3 Trials Gene Therapy RNA-based Therapeutics Therapeutic Targets Drug Testing Research Applications Compounding Pharmacies Obesity Treatments Injectable Medications Disease Treatment FDA Regulations

Alumis Shares Plunge After Phase 2b Lupus Trial Misses Primary Goal

A strong prespecified interferon‑high (IFNGS‑high) subgroup response gives the company a path to pursue a biomarker‑focused Phase 3.

Sandoz Signs Exclusive Deal to Commercialize Up to 10 Henlius Biosimilars

Pomerantz Files Securities Class Action Against Nektar Over REZOLVE‑AA Trial Disclosures

Clearmind’s AUD Candidate Meets Early Safety Goal as Shares Double

FDA Issues Second Rejection of Replimune’s RP1 Melanoma Therapy

Insmed Halts Brensocatib in Hidradenitis Suppurativa After Phase 2b Trial Fails

Priovant’s Brepocitinib Posts Strong Phase 2 Win in Cutaneous Sarcoidosis

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

Genmab Halts Acasunlimab to Focus on Late-Stage Cancer Portfolio

New iGluSnFR4 Sensor Lets Scientists See Neurons’ Incoming Signals in Living Brains

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion

BioCryst to Acquire Astria in $700 Million Cash-and-Stock Deal to Bolster HAE Portfolio

Moonlake Shares Plunge on Mixed Phase 3 Results for Hidradenitis Drug

Study Identifies Immune ‘Protein Battery’ That Speeds Defense but May Fuel Aging Inflammation

Johns Hopkins Researchers Grow Vascularized Whole-Brain Organoid With Network-Level Activity

Scientists Create Functional Blood Vessels and Liver Lobules on Microfluidic Chips

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies